Loading...
Header Logo
Keywords
Last Name

Connection

Search Results to Steven R. Feldman, M.D., Ph.D.

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Feldman, Steven

Item TypeName
Academic Article The promise and challenge of new biological treatments for psoriasis: how do they impact quality of life?
Academic Article Eligibility creep: a cause for placebo group improvement in controlled trials of psoriasis treatments.
Academic Article Cost-effectiveness of biologic treatments for psoriasis based on subjective and objective efficacy measures assessed over a 12-week treatment period.
Academic Article Drug Safety.
Academic Article Psoriasis and its treatment with adalimumab.
Academic Article Comparing the lifetime risks of TNF-alpha inhibitor use to common benchmarks of risk.
Academic Article Tattoo sites and psoriasis.
Academic Article Interleukin-23 and interleukin-17: importance in pathogenesis and therapy of psoriasis.
Academic Article Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial.
Academic Article Infliximab for inpatient psoriasis management--is there a role?
Academic Article New treatments for psoriasis: which biologic is best?
Academic Article A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis.
Academic Article Misunderstandings.
Academic Article Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.
Academic Article Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics.
Academic Article Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: results from a randomized, controlled Phase III study.
Academic Article Efficacy of systemic treatments for moderate to severe plaque psoriasis: systematic review and meta-analysis.
Academic Article Economic evaluation of biologic therapies for the treatment of moderate to severe psoriasis in the United States.
Academic Article Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis.
Academic Article Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial.
Academic Article Cost per responder analysis of ustekinumab and etanercept for moderate to severe plaque psoriasis.
Academic Article Infections associated with the use of tumor necrosis factor-a inhibitors in psoriasis.
Concept Antibodies, Monoclonal
Academic Article Cost effectiveness of biologic therapies for plaque psoriasis.
Academic Article Department of Dermatology was blessed with a wonderful psoriasis specialist. Foreword.
Academic Article Adherence to adalimumab in patients with moderate to severe psoriasis.
Academic Article Adherence to ustekinumab in psoriasis patients.
Academic Article Trends in systemic psoriasis treatment therapies from 1993 through 2010.
Academic Article The 5-point Investigator's Global Assessment (IGA) Scale: A modified tool for evaluating plaque psoriasis severity in clinical trials.
Academic Article Dupilumab for the treatment of atopic dermatitis: A clinical trial review.
Academic Article Differences in psoriasis signs and symptom severity between patients with clear and almost clear skin in clinical practice.
Academic Article Interleukin-31 pathway and its role in atopic dermatitis: a systematic review.
Academic Article Assessing the overall benefit of a medication: cumulative benefit of secukinumab over time in patients with moderate-to-severe plaque psoriasis.
Academic Article Dupilumab for atopic dermatitis.
Academic Article Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease.
Academic Article Treating Moderate-to-Severe Plaque Psoriasis With Guselkumab: A Review of Phase II and Phase III Trials.
Academic Article Adherence to biologics in patients with psoriasis.
Academic Article Secukinumab improves scalp pain, itching, scaling and quality of life in patients with moderate-to-severe scalp psoriasis.
Academic Article Higher Psoriasis Skin Clearance Is Associated with Lower Annual Indirect Costs in the United States: A Post Hoc Analysis from the CLEAR Study.
Academic Article Comparison of the cost-effectiveness of biologic drugs used for moderate-to-severe psoriasis treatment in the United States.
Academic Article The budget impact of brodalumab for the treatment of moderate-to-severe plaque psoriasis on US commercial health plans.
Academic Article Cost Per Additional Responder Associated With Ixekizumab and Etanercept in the Treatment of Moderate-to-Severe Psoriasis.
Academic Article Risankizumab for psoriasis.
Academic Article Relative efficacy of systemic treatments for atopic dermatitis.
Academic Article Secukinumab for psoriasis in a patient with hepatitis B.
Academic Article Current biological therapies for use in HIV-positive patients with psoriasis: case report of gesulkumab used and review.

Search Criteria
  • Antibodies Monoclonal